Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study (Q37397995)
Jump to navigation
Jump to search
scientific article published on 14 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study |
scientific article published on 14 May 2013 |
Statements
1 reference
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study (English)
1 reference
E Stadtmauer
1 reference
F Buadi
1 reference
A J Jakubowiak
1 reference
D S Siegel
1 reference
T Martin
1 reference
M Wang
1 reference
R Vij
1 reference
S Lonial
1 reference
S Trudel
1 reference
V Kukreti
1 reference
N Bahlis
1 reference
M Alsina
1 reference
A Chanan-Khan
1 reference
F J Reu
1 reference
G Somlo
1 reference
J Zonder
1 reference
K Song
1 reference
A K Stewart
1 reference
B L Harrison
1 reference
A F Wong
1 reference
R Z Orlowski
1 reference
S Jagannath
1 reference
14 May 2013
1 reference
1 reference
2351-2356
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference